Enzymotec Ltd
ENZY
ENZY was delisted on the 10th of January, 2018.
20 hedge funds and large institutions have $40.7M invested in Enzymotec Ltd in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 6 closing their positions.
5% less funds holding
Funds holding: 21 → 20 (-1)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
19% less capital invested
Capital invested by funds: $50.3M → $40.7M (-$9.59M)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$784K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$253K |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$159K |
| 4 |
GP
GLG Partners
London,
United Kingdom
|
+$159K |
| 5 |
OWD
Osborn Williams & Donohoe
Cincinnati,
Ohio
|
+$118K |
Top Sellers
| 1 |
PC
Paulson & Co
New York
|
-$20.8M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$2.35M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.76M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.07M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$553K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
State of Tennessee, Department of Treasury
Nashville,
Tennessee
| – | -$26K | -3,198 | Closed |
|
ENZY Hedge Fund Activity: Q3 2017 in Review
20 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Enzymotec Ltd (ENZY) for Q3 2017, worth a combined $40.7M — down 19% from $50.3M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of ENZY and 5 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 5 added.
The largest buyer was Renaissance Technologies, adding an estimated $784K. The largest seller was Paulson & Co, cutting an estimated $20.8M.
- 20 institutional investors held Enzymotec Ltd (ENZY) as of Q3 2017, down from 21 in Q2 2017.
- Funds reported $40.7M of Enzymotec Ltd stock for Q3 2017, down 19% quarter-over-quarter.
- 5 funds opened new Enzymotec Ltd positions in Q3 2017 and 6 closed out, a net change of -1 holder.
- The largest Enzymotec Ltd buyer in Q3 2017 was Renaissance Technologies, an estimated $784K added.
- The largest Enzymotec Ltd seller in Q3 2017 was Paulson & Co, an estimated $20.8M sold.
Based on aggregated 13F filings for Q3 2017.